752 related articles for article (PubMed ID: 21983253)
1. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
[TBL] [Abstract][Full Text] [Related]
4. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
[TBL] [Abstract][Full Text] [Related]
5. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population.
Delaney KP; Heffelfinger JD; Wesolowski LG; Owen SM; Meyer WA; Kennedy S; Uniyal A; Kerndt PR; Branson BM
J Clin Virol; 2011 Dec; 52 Suppl 1():S5-10. PubMed ID: 22019251
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.
Masciotra S; McDougal JS; Feldman J; Sprinkle P; Wesolowski L; Owen SM
J Clin Virol; 2011 Dec; 52 Suppl 1():S17-22. PubMed ID: 21981983
[TBL] [Abstract][Full Text] [Related]
7. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
[TBL] [Abstract][Full Text] [Related]
8. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections.
Nasrullah M; Ethridge SF; Delaney KP; Wesolowski LG; Granade TC; Schwendemann J; Boromisa RD; Heffelfinger JD; Owen SM; Branson BM
J Clin Virol; 2011 Dec; 52 Suppl 1():S23-7. PubMed ID: 21993309
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data.
Styer LM; Sullivan TJ; Parker MM
J Clin Virol; 2011 Dec; 52 Suppl 1():S35-40. PubMed ID: 22018662
[TBL] [Abstract][Full Text] [Related]
11. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
Manlutac AL; Giesick JS; McVay PA
J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
[TBL] [Abstract][Full Text] [Related]
13. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
Dubravac T; Gahan TF; Pentella MA
J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
[TBL] [Abstract][Full Text] [Related]
15. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
Patel P; Mackellar D; Simmons P; Uniyal A; Gallagher K; Bennett B; Sullivan TJ; Kowalski A; Parker MM; LaLota M; Kerndt P; Sullivan PS;
Arch Intern Med; 2010 Jan; 170(1):66-74. PubMed ID: 20065201
[TBL] [Abstract][Full Text] [Related]
16. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.
Pumarola T; Freeman J; Saxton E; Dillon P; Bal T; van Helden J
J Virol Methods; 2010 Dec; 170(1-2):16-20. PubMed ID: 20723562
[TBL] [Abstract][Full Text] [Related]
18. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
[TBL] [Abstract][Full Text] [Related]
19. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection.
Ethridge SF; Wesolowski LG; Nasrullah M; Kennedy MS; Delaney KP; Candal D; Owen SM
J Clin Virol; 2011 Dec; 52 Suppl 1():S63-6. PubMed ID: 21995932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
